These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11976837)

  • 1. Radiolabeled 2'-fluorodeoxyuracil-beta-D-arabinofuranoside (FAU) and 2'-fluoro-5-methyldeoxyuracil-beta -D-arabinofuranoside (FMAU) as tumor-imaging agents in mice.
    Wang H; Oliver P; Nan L; Wang S; Wang Z; Rhie JK; Zhang R; Hill DL
    Cancer Chemother Pharmacol; 2002 May; 49(5):419-24. PubMed ID: 11976837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl) uracil in mice bearing colorectal cancer xenografts: rationale for therapeutic use and as a positron emission tomography probe for thymidylate synthase.
    Eiseman JL; Brown-Proctor C; Kinahan PE; Collins JM; Anderson LW; Joseph E; Hamburger DR; Pan SS; Mathis CA; Egorin MJ; Klecker RW
    Clin Cancer Res; 2004 Oct; 10(19):6669-76. PubMed ID: 15475457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of capecitabine treatment on the uptake of thymidine analogs using exploratory PET imaging agents:
    McHugh CI; Lawhorn-Crews JM; Modi D; Douglas KA; Jones SK; Mangner TJ; Collins JM; Shields AF
    Cancer Imaging; 2016 Oct; 16(1):34. PubMed ID: 27751167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging DNA synthesis in vivo with 18F-FMAU and PET.
    Sun H; Mangner TJ; Collins JM; Muzik O; Douglas K; Shields AF
    J Nucl Med; 2005 Feb; 46(2):292-6. PubMed ID: 15695789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging [18F]FAU [1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl) uracil] in dogs.
    Sun H; Collins JM; Mangner TJ; Muzik O; Shields AF
    Nucl Med Biol; 2003 Jan; 30(1):25-30. PubMed ID: 12493539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of the thymidine analog 2'-fluoro-5-methyl-1-beta-D-arabinofuranosyluracil (FMAU) in tumor-bearing rats.
    Bading JR; Shahinian AH; Vail A; Bathija P; Koszalka GW; Koda RT; Alauddin MM; Fissekis JD; Conti PS
    Nucl Med Biol; 2004 May; 31(4):407-18. PubMed ID: 15093810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative kinetics of [124I]FIAU in cat and man.
    Jacobs A; Bräunlich I; Graf R; Lercher M; Sakaki T; Voges J; Hesselmann V; Brandau W; Wienhard K; Heiss WD
    J Nucl Med; 2001 Mar; 42(3):467-75. PubMed ID: 11337525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rat studies comparing 11C-FMAU, 18F-FLT, and 76Br-BFU as proliferation markers.
    Lu L; Samuelsson L; Bergström M; Sato K; Fasth KJ; Långström B
    J Nucl Med; 2002 Dec; 43(12):1688-98. PubMed ID: 12468521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging DNA synthesis with [18F]FMAU and positron emission tomography in patients with cancer.
    Sun H; Sloan A; Mangner TJ; Vaishampayan U; Muzik O; Collins JM; Douglas K; Shields AF
    Eur J Nucl Med Mol Imaging; 2005 Jan; 32(1):15-22. PubMed ID: 15586282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of 2'-deoxy-2'-[18F]fluoro-5-methyl-1-beta-L: -arabinofuranosyluracil ([18F]-L: -FMAU) as a PET imaging agent for cellular proliferation: comparison with [18F]-D: -FMAU and [18F]FLT.
    Nishii R; Volgin AY; Mawlawi O; Mukhopadhyay U; Pal A; Bornmann W; Gelovani JG; Alauddin MM
    Eur J Nucl Med Mol Imaging; 2008 May; 35(5):990-8. PubMed ID: 18057932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct comparison of radiolabeled probes FMAU, FHBG, and FHPG as PET imaging agents for HSV1-tk expression in a human breast cancer model.
    Alauddin MM; Shahinian A; Gordon EM; Conti PS
    Mol Imaging; 2004 Apr; 3(2):76-84. PubMed ID: 15296672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Journey of 2'-deoxy-2'-fluoro-5-methyl-1-β-D-arabinofuranosyluracil (FMAU): from Antiviral Drug to PET Imaging Agent.
    Alauddin MM
    Curr Med Chem; 2018; 25(16):1867-1878. PubMed ID: 29189119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating Dynamic Positron Emission Tomography and Conventional Pharmacokinetic Studies to Delineate Plasma and Tumor Pharmacokinetics of FAU, a Prodrug Bioactivated by Thymidylate Synthase.
    Li J; Kim S; Shields AF; Douglas KA; McHugh CI; Lawhorn-Crews JM; Wu J; Mangner TJ; LoRusso PM
    J Clin Pharmacol; 2016 Nov; 56(11):1433-1447. PubMed ID: 27095537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [18F]-2'-Fluoro-5-methyl-1-beta-D-arabinofuranosyluracil (18F-FMAU) in prostate cancer: initial preclinical observations.
    Jadvar H; Yap LP; Park R; Li Z; Chen K; Hughes L; Kouhi A; Conti P
    Mol Imaging; 2012; 11(5):426-32. PubMed ID: 22954187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of the thymidine analog 2'-fluoro-5-[(14)C]-methyl-1-beta-D-arabinofuranosyluracil ([(14)C]FMAU) in rat prostate tumor cells.
    Bading JR; Shahinian AH; Bathija P; Conti PS
    Nucl Med Biol; 2000 May; 27(4):361-8. PubMed ID: 10938471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Androgen on Normal Biodistribution of [
    Jadvar H; Park R; Yap LP; Chen K; Hughes L; Conti P
    Anticancer Res; 2017 Feb; 37(2):475-479. PubMed ID: 28179292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring tumor cell proliferation by targeting DNA synthetic processes with thymidine and thymidine analogs.
    Schwartz JL; Tamura Y; Jordan R; Grierson JR; Krohn KA
    J Nucl Med; 2003 Dec; 44(12):2027-32. PubMed ID: 14660729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of labeled thymidine analogs for imaging tumor proliferation.
    Shields AF; Grierson JR; Kozawa SM; Zheng M
    Nucl Med Biol; 1996 Jan; 23(1):17-22. PubMed ID: 9004909
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.